- Our Doctors
- Dr Bradley Wong
Dr Bradley Wong
MBBS, FRANZCR, Radiation Oncologist
I believe that the best outcomes for patients and their families are achieved by combining modern technology, evidence-based medicine, and a holistic approach to the patient.
Languages spoken
English
Overview
Centres
Clinical interests
Clinical interests include skin, prostate, urological and breast cancer, palliative radiation therapy, benign conditions, SABR and tattoo-less breast radiotherapy
Brad completed a Bachelor of Medicine and Surgery (MBBS) at the University of Adelaide before undertaking his radiation oncology training in South Australia. In 2015 he was awarded Fellowship to the Royal Australian and New Zealand College of Radiologists (FRANZCR). He practices as a consultant radiation oncology specialist with GenesisCare in Buderim and Noosa with an outreach clinic in Gympie.
Brad is dedicated to offering personalised care through the provision of modern treatment techniques including volumetric modulated arc therapy (VMAT), image guided radiation therapy (IGRT), deep inspiration breath hold (DIBH), tattoo-less breast radiotherapy, stereotactic ablative body radiotherapy (SABR) and the use of rectal spacing to reduce side effects in prostate cancer patients. In recent years Brad has presented at a number of medical conferences on the topics of skin cancer and prostate cancer. He regularly participates in multidisciplinary team meetings and believes in a holistic approach to patient care.
Brad has been involved in clinical teaching and has been awarded the academic title of Senior Lecturer at the University of Queensland School of Medicine. He is an active participant in clinical research and is currently recruiting to the PREDICT study to improve outcomes for patients with ductal carcinoma in situ (DCIS) of the breast and to the ASTuTE study for patients with intermediate risk prostate cancer. His current major technical interests are in the use of custom bolus for wide field skin treatments.
Brad works across many tumour types and has clinical interests in the management of skin cancer, prostate cancer, urological cancers, breast cancer, benign conditions, and palliative care.
Awards
- Senior Lecturer, School of Medicine, University of Queensland
- Clinical Examiner, School of Medicine, University of Queensland, Rural Clinical School, Bundaberg
- Fellowship of the Royal Australian and New Zealand College of Radiologists (FRANZCR)
Research interests
- PREDICT study for patients with ductal carcinoma in situ (DCIS) of the breast
- ASTuTE study for patients with intermediate risk prostate cancer
- Skin cancer treatments using modern technology including the creation of custom bolus
Professional memberships
- Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP)
- Urological Society of Australia and New Zealand (USANZ)
- Australasian Society for Breast Disease (ASBD)
- International Dupuytren Society
- International Organisation for Radiotherapy for Benign Conditions (IORBC)
- Royal Australian & New Zealand College of Radiologists (RANZCR)
- Trans-Tasman Radiation Oncology Group (TROG)
- Breast Cancer Trials Group (BCT)
Publications
- A multicentre implementation trial of an Artificial Intelligence-driven biomarker to inform Shared decisions for androgen deprivation therapy in men undergoing prostate radiotherapy: the ASTuTE protocol, BMC Cancer, 2025
- Keratinocyte cancer of the lower limb in the frail elderly – acceptable results for 96 lesions treated with a shortened radiotherapy protocol: International Journal of Radiology & Radiation Therapy, 2024
- Modern radiation therapy for keratinocyte cancer: What the general practitioner needs to know, The Australian Journal of General Practice, 2024
- Efficacy and safety analysis: 24‐month outcomes from a prospective cohort of 106 fields treated with widefield radiation therapy for extensive skin field cancerization, with or without keratinocyte cancers, Journal of the European Academy of Dermatology & Venereology, 2023
- Novel radiation approach using volumetric modulated arc therapy for patients with extensive skin field cancerisation and keratinocyte cancers: promising efficacy and safety results for 83 patients, Journal of Dermatological Treatment, 2022
- Role of radiation therapy in the management of patients with widespread non-melanoma skin cancer in regional communities, Dermatology Republic, 2022
- Volumetric modulated arc therapy (VMAT) for extensive skin field cancerisation (ESFC) – exploring the limits of treatment volumes with a case series of backs, International Journal of Radiology & Radiation Therapy, 2020
- Experiences in growing a skin radiation therapy practice, International Journal of Radiology & Radiation Therapy, 2020
- A technique for treating extended skin field cancerisation using volumetric modulated arc therapy, International Journal of Radiology & Radiation Therapy, 2019
- Glomus Jugulare Tumours: A fifteen year radiotherapy experience in South Australia, Journal of Clinical Neuroscience, 2014
Disclaimer:
This website is provided for information purposes only. Nothing on this website is intended to be used as medical advice, or to diagnose, treat, cure or prevent any disease. It should not be used as a substitute for your own health professional's advice. Any medical procedure or treatment carries risks. Before proceeding with treatment, you should discuss the risks and benefits of the treatment with an appropriately qualified health practitioner. Individual treatment outcomes and experiences will vary.